There are several enzymes that generate acetyl-CoA in the mammals, including pyruvate dehydrogenase, which converts pyruvate to acetyl-CoA without generating free acetate. The degradation of fatty acid via β-oxidation system also produces acetyl-CoA as an end product. Although acetate is not an essential source of acetyl-CoA in animals, the enzymatic ligation for the production of acetyl-CoA from acetate and
INTORODUCTION

Acetyl-CoA is an important intermediate in various metabolic pathways including
fatty acid and cholesterol biosynthesis and the energy production by the citric acid cycle.
There are several enzymes that generate acetyl-CoA in the mammals, including pyruvate dehydrogenase, which converts pyruvate to acetyl-CoA without generating free acetate. The degradation of fatty acid via β-oxidation system also produces acetyl-CoA as an end product. Although acetate is not an essential source of acetyl-CoA in animals, the enzymatic ligation for the production of acetyl-CoA from acetate and
CoA is a key reaction in the catabolism of acetate formed by several conditions including bacterial fermentation in the colon, oxidation of ingested ethanol in the liver.
Acetyl-CoA synthetase (AceCS, EC6.2.1.1) is an enzyme that catalyzes the production of acetyl-CoA from acetate and CoA. In particular, this enzyme plays a key role in the nervous system for recycling of acetate released by acetylcholine esterase for the formation and release of acetylcholine in cholinergic nerve terminals.
There are two AceCSs with similar enzymatic properties in mammals: one designated AceCS1 is a cytosolic enzyme and the other, designated AceCS2, is a mitochondrial matrix enzyme (1) . Localized in the cytoplasm, AceCS1 provides acetyl-CoA for the synthesis of fatty acids and cholesterol. In contrast, AceCS2 produces acetyl-CoA for oxidation through the citric acid cycle to produce ATP and CO 2 in the mitochondrial matrix.
AceCS1 is a member of a family of genes whose transcription is regulated by sterol regulatory element-binding proteins (SREBPs), a basic helix-loop-helix leucine zipper transcription factor that activates multiple genes for cholesterol and fatty acid metabolism (2, 3) . The levels of AceCS1 mRNA was induced when cultured cells were deprived of sterols and negatively regulated by sterol addition. In our previous study, we have shown that the AceCS1 promoter region consists of multiple clustered SREBP binding sites and immediately downstream from this region there is a cluster of multiple GC-boxes (3) . All these SREBP binding sites are bound with purified SREBP-1a and are required for a maximal response to co-transfected SREBP. The sterol regulation of the AceCS1 gene was critically dependent on three closely spaced SREBP binding sites and an adjacent GC-box. We also showed that SREBP synergistically activated the AceCS1 promoter along with Sp1 or Sp3 but not with NF-Y.
AceCS2 is highly expressed in the cardiac and skeletal muscle and its regulation is completely different from that of AceCS1. A marked induction of AceCS2 mRNA is seen in the heart and skeletal muscle when animals are fasted (1) . The levels of AceCS2 mRNA in the skeletal muscle of Zucker diabetic fatty rats were also increased compared with those in the normal littermates. These data indicated that the AceCS2 transcripts are induced in the heart and skeletal muscle under ketogenic conditions including prolonged fasting and diabetes.
During fasting, the expression of more than 94% of genes is not altered in the skeletal muscle. Among genes that are differentially expressed during fasting, genes involved in protein breakdown (components of the ubiquitin-proteasome pathway), fatty acid oxidation, and pyruvate dehydrogenase kinase 4 (PDK4) that suppresses glucose oxidation by inhibiting pyruvate dehydrogenase complex activity, are upregulated (4, 5) .
In contrast, genes encoding glycolytic enzymes are downregulated by fasting. Induction of genes involved in fatty acid oxidation is also seen in the skeletal muscle of diabetic mice (6) . Although these changes indicate a complex adaptive program for sparing glucose, the mechanism underlining transcriptional regulation is not fully understood.
gene from X chromosome (AFX), and pIRS-MLP-luc, a luciferase reporter plasmid driven by a promoter consisting of three tandem copies of a insulin responsive sequence (IRS) plus the adenovirus major late promoter (MLP) from Dr. A. Fukamizu (Center of Tsukuba Advanced Research Alliance, Institute of Applied Biochemistry, University of Tsukuba) (10,11); pcDNA3.1-based plasmid for human c-Ets-1 from Dr. T. Minami (Laboratory for Systems Biology and Medicine, University of Tokyo, Japan) (12); and pcDNA3-based plasmids for mouse hepatic nuclear factor 1α (HNF1α) and mouse hepatic nuclear factor 1β (HNF1β) from Dr. K. Yamagata (Second Department of Internal Medicine, Osaka University Medical School, Suita, Japan.) (13, 14) .
pCMV-MyoD, a CMV-driven plasmid for mouse MyoD, was constructed inserting the reverse transcription-PCR products of C2C12 myotube RNA into the pcDNA3 vector.
pPac, a Drosophila actin 5C promoter-driven expression vector, pPacβ-gal containing an E. coli β-galactosidase, and pPacSp1 and pPacSp3, respectively, containing Sp1 and Sp3, were provided by Dr. G. Suske (Philipps-Universität Marburg, Germany).
pPac-based plasmid encoding rat KLF15 was generated by inserting the KLF15 cDNA into the pPac vector. An Sp1-GST fusion construct, pGEX-Sp1, was prepared by inserting the Sp1 cDNA fragment into the XhoI site of pGEX-4T-2.
Cloning of 5'-flanking Region of Mouse AceCS2 gene---
The 5'-flanking region of the mouse AceCS2 gene was cloned by PCR using Mouse Genome Walker kits (Clontech) as described previously (3) . Briefly, the first PCR was conducted with adaptor primer 1 (provided by the supplier) and AceCS2 primer 1 (5'-TGACCACCCCGAT TGTCCAGAG-3') on a mouse genomic library (provided by the supplier). Nested PCR was then carried out with adaptor primer 2 (provided by the supplier) and AceCS2 primer 2 (5'-CGCAGCAGTCGCCCCACACCGCTGC-3') on the first PCR products. The resulting 2.4-kb PCR product was subcloned into the pGEM-T easy cloning vector (Promega) to create pGEM-5'FL-AceCS2. Sequencing of the insert of pGEM-5'FL-AceCS2 was performed in both directions by the PCR cycle sequence method with an automatic sequence analyzer (Beckman Coulter CEQ 2000XL DNA Analysis System). C2C12 cells and HSkMC were maintained in medium A and differentiated into myotubes in medium B (DMEM containing 100 units/ml penicillin, 100 µg/ml of streptomycin sulfate and 2% horse serum) for 5 days.
Rapid Amplification of cDNA End (RACE)---5'-RACE
Schneider line 2 (SL2) cells, an Sp-null Drosophila cell line, were purchased from Invitrogen, maintained in Schneider's medium containing 100 units/ml penicillin and 100 µg/ml streptomycin sulfate, supplemented with 10% fetal bovine serum, and grown at 23 °C.
HEK293 and SL2 cells were transfected in 24-well plates using LipofectAMINE PLUS as described previously (15) . After 24 h, the cells were lysed with 0.1 ml of 1 × passive lysis buffer (Promega), and aliquots were used for the measurement of firefly
and Renilla luciferase activities as described below. For SL2 cells, β-galactosidase activities were determined using Luminescent β-galactosidase Reporter System (Clontech) and luciferase activities were normalized by the β-galactosidase activities (relative light unit).
Retroviral Vectors and Infection---
The plat-E retroviral packaging cell line (16) , and the retroviral vector pWZL containing the blasticidin S resistance gene were, respectively, provided by Drs. T. Kitamura (University of Tokyo, Tokyo, Japan) and G.
P. Nolan (Stanford University, Palo Alto, CA). KLF15 cDNA was subcloned into the retrovirus vector, pWZL, to generate pWZL-KLF15.
To generate C2C12 cells stably expressing KLF15, the cells were infected with the retroviral vectors pWZL-KLF15 as described by Pear (17) Animal Manipulation---Male ICR mice were purchased from CLEA Japan, Inc (Tokyo, Japan). The mice were housed in a temperature-and humidity-controlled (26.5 °C and 35%, respectively) facility with a 12 h light/dark cycle (dark cycle was between 20.00-8.00). Mice were allowed to free access of water and a normal chow diet (CE-2, CLEA Japan) before experiments. Mice (7-8 weeks of age) were randomly divided into two groups: one group was fed ad libitum with regular diet and the other group was fasted for 48 h. All mice were sacrificed at the same time between 9.00-11.00
AM. Quadriceps muscles were removed, weighed, and immediately frozen in liquid nitrogen and stored at -80 °C until RNA was extracted. Mouse cyclophilin or human GAPDH mRNA was used as the invariant control. mM KCl, 0.125 mM EDTA, 0.5 mM dithiothreitol, and 0.5 mg/ml poly(dI-dC) for 30 min at room temperature. For competition experiments, excess (100-fold) unlabeled double-stranded oligonucleotide was added to the binding mixture. In the supershift experiment, an antibody for KLF15 (2.5 µg) was added to the binding reaction.
Quantitative Real Time PCR---First
Preparation of Nuclear Extracts and Electrophoretic Mobility Shift Assay (EMSA)---For
Protein-DNA complexes were analyzed by electrophoresis on 6% polyacrylamide gels as described previously (3). 0.05% Nonidet P-40, 2 mM dithiothreitol, and 10% glycerol). The beads were washed seven times with the same buffer, and subjected to SDS-polyacrylamide gel electrophoresis and autoradiography.
GST Pull-down Analysis---[
RESULTS
Effects of Insulin on levels of AceCS2 Transcripts in Skeletal Muscle---We
previously showed that fasting robustly increases the levels of AceCS2 mRNA in the skeletal muscle. There are several known fasting-inducible genes that are negatively regulated by insulin (19) . These include genes encoding phosphoenolpyruvate carboxykinase (20) , insulin-like growth factor-binding protein-1 (20) , insulin receptor substrate-2 (21), and aquaporin adipose (22) . To determine whether insulin negatively regulates the expression of AceCS2, we used C2C12 and human myotubes. As a positive control for the insulin response in C2C12 myotubes, we have analyzed the mRNA levels of two well known insulin responsive genes, hexokinase II and PDK4:
hexokinase II and PDK4 are, respectively, up-and down-regulated by insulin. Cells were incubated with or without insulin for various time periods and the levels of AceCS2, hexokinase II, and PDK4 mRNAs were determined by quantitative real-time PCR. As shown in Fig. 1A , insulin treatment did not alter the levels of AceCS2 mRNA, whereas those of hexokinase II and PDK4 were, respectively, induced and reduced by insulin treatment. Similarly, the levels of AceCS2 mRNA in human skeletal myotubes was not altered (Fig.1B) , suggesting that fasting-induced AceCS2 gene expression is not directly dependent on insulin action. PROCEDURES") and was sequenced ( Fig. 2A) . The transcription initiation sites were determined by 5'-RACE experiments on poly(A) + RNA from mouse skeletal muscle using an AceCS2 transcript-specific primer (see "EXPERIMENTAL PROCEDURES").
Sequence analysis of the 5'-RACE products revealed that the AceCS2 gene has multiple transcription start sites: two major points at -23 and -28 and four minor points at -12, -17, -19 and -53 (Fig.2A) ; the A of the translation initiation ATG of the gene is designated +1. 
Trans-activation of AceCS2 promoter by KLF 15---Potential
Electrophoretic Mobility Shift Assay (EMSA) of KLF15-Binding Site in the AceCS2
Promoter---To determine whether KLF15 is capable of binding to the most proximal KLF site of the AceCS2 promoter, we performed EMSA using labeled probe (double-stranded 36-mer corresponding -70 to -105) with the nuclear extracts from C2C12 cells stably expressing KLF15. As shown in Fig. 5 , the nuclear extracts containing KLF 15 produced a single band of DNA-protein complex. This complex was specific as it can be competed by unlabeled probe. Furthermore, this complex can be supershifted with an antibody against KLF15, indicating that KLF15 is able to bind to the most proximal KLF site to the transcription start point of the AceCS2 gene. To determine whether KLF15 and Sp1 interact directly to activate the AceCS2 promoter, we carried out GST pull-down assays. As shown in Fig. 7 Table II, 48 h fasting robustly induced the KLF15 transcripts in the skeletal muscle of mice: the levels of KLF15 transcripts in fasted animals were ~28-fold higher than those in fed animals.
Synergistic Transcriptional Activation by KLF15 and Sp1---In
Together with the transactivation of the AceCS2 promoter, it is suggested that this fasting-induced AceCS2 expression is largely contributed by KLF15. Each value represents the average of duplicate incubations. GCTTGAAAGA CAAGGGGACC TGGAGGGGAA AGTGGAGGAT TGAGAACTCC  -2040  AGCACTTTGA AGACAAGGAG AGAGAAGACA ACGCGTGCAG GGGATGAGGT GTAGGAACTG  -1980  GCAAAGGGAA GGCCTCACAT TTTAGGAGTA GTTTTTGTGC CAGCTAGCTA CAGCTGAGTA  -1920  ATAAAGTTAA GATTATCTGA GACTTCTTCC AACCTCGCAA ATCACTAGAA AGGCCTTTTG  -1860  TGCTGAGGGT GAGGCTCCAT ACCTGGTATA GAGCAGCCAA GGTGGATGCA CATCTGTCCA  inverted KLF  -1800  GAGCTGTTCC TGGTTGTGGG CTGGTGCAAC TCAGTCTCTC TGTGGGTTCT TTGCCCCCAG  -1740  AAGGCAGGAC CAACTCCCTC ACACCATGGC AGCTGGGAAC CAACCAACCA AAAAAAAAAG  -1680  AAGCAGCACA CAGGGTTTCC TCAACACAGC CTTGGCATCT AGCCAGCCTG TCAAAGTATC  -1620  ACTTCTGCCA TGTCCTCTGG AGTAAAGCTA GGAGGTCAGC TAGCCTGGAT CTTCATCCTT  -1560  TTAGAGGGTT ATGCATGCTG ACAGTAGAAC TCAGGGCCTG TGCATGCTAG GC-Box mut GC-Box
Overexpression of KLF15 in C2C12 Myogenic Cells Induces the Expression of AceCS2 transcripts---We
